Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 129.44 BATS BZX Real-Time Price As of 12:03pm ET |  +2.72 / +2.15%Today’s Change | 67.81 Today|||52-Week Range 129.87 | +43.38% Year-to-Date |
| Nevro Hits New 52-Week High on Solid HF10 Therapy Sales Sep 26 / Zacks.com - Paid Partner Content | CryoLife Hits a 52-Week High on Strong Growth Prospects Sep 23 / Zacks.com - Paid Partner Content |
| Patterson Companies Faces Multiple Issues: Dump Now? Sep 26 / Zacks.com - Paid Partner Content | Thermo Fisher Adds FEI Co., Inorganic Expansion Continues Sep 20 / Zacks.com - Paid Partner Content |
| Previous close | 126.72 |
| Today’s open | 127.11 |
| Day’s range | 126.56 - 129.87 |
| Volume | 19,092 |
| Average volume (3 months) | 508,535 |
| Market cap | $5.5B |
| Dividend yield | -- |
| Earnings growth (last year) | -67.92% |
| Earnings growth (this year) | +37.91% |
| Earnings growth (next 5 years) | +27.50% |
| Revenue growth (last year) | +43.09% |
| P/E ratio | 137.7 |
| Price/Sales | 12.92 |
| Price/Book | 14.64 |
| Today’s change | Today’s % change | |
|---|---|---|
| WSTWest Pharmaceutical ... | +0.98 | +1.37% |
| TFXTeleflex Inc | -0.24 | -0.14% |
| CMNCantel Medical Corp | -0.36 | -0.45% |
| NUVANuVasive Inc | +0.40 | +0.60% |
| Next reporting date | October 27, 2016 |
| EPS forecast (this quarter) | $0.24 |
| Annual revenue (last year) | $329.5M |
| Annual profit (last year) | $38.1M |
| Net profit margin | 11.58% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael R. Minogue |
Chief Operating Officer David M. Weber |
Corporate headquarters Danvers, Massachusetts |
